Profound Medical PROF Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Capital Equipment | $8.41M+32.1% | $6.37M+52.3% | $4.18M+33.3% | $3.14M-3.8% | $3.26M+33.6% | |
| Recurring Non Capital | $10.4M+6.9% | $9.73M-3.8% | $10.12M+16.2% | $8.7M+1.2% | $8.6M+4.4% | |
| Revenue by Geography | ||||||
| CA | $5.8M+88.3% | $3.08M+39.4% | $2.21M-8.3% | $2.41M-24.4% | $3.19M+30.7% | |
| DE | $697K-9.8% | $773K+12.7% | $686K-16.3% | $820K-12.8% | $940K+5.5% | |
| US | $12.32M+0.6% | $12.25M+7.4% | $11.4M+32.4% | $8.61M+11.3% | $7.74M+5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Profound Medical break its business down?
- Profound Medical (PROF) reports revenue by product across 2 parts — Capital Equipment and Recurring Non Capital. Each is extracted from the segment footnotes and tracked over time.
- Where does Profound Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Profound Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
